Io­n­is scraps CF pro­gram in an­oth­er set­back for the dis­ease and the com­pa­ny

Io­n­is an­nounced on Fri­day they would kill an ear­ly-stage ef­fort for cys­tic fi­bro­sis, drop­ping out of a medi­um-pro­file race with two oth­er RNA-fo­cused biotechs and …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER